Gary J. Okano

853 total citations
22 papers, 698 citations indexed

About

Gary J. Okano is a scholar working on Geriatrics and Gerontology, Economics and Econometrics and Pathology and Forensic Medicine. According to data from OpenAlex, Gary J. Okano has authored 22 papers receiving a total of 698 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Geriatrics and Gerontology, 6 papers in Economics and Econometrics and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Gary J. Okano's work include Pharmaceutical Practices and Patient Outcomes (7 papers), Platelet Disorders and Treatments (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Gary J. Okano is often cited by papers focused on Pharmaceutical Practices and Patient Outcomes (7 papers), Platelet Disorders and Treatments (5 papers) and Health Systems, Economic Evaluations, Quality of Life (5 papers). Gary J. Okano collaborates with scholars based in United States, Belgium and United Kingdom. Gary J. Okano's co-authors include Sansei Nishibe, Hajime Takeda, Daniel C. Malone, Karen L. Rascati, Sarah J. Billups, Charles D. Sintek, Debra J. Barnette, Robert J. Valuck, Robert Dombrowski and Kelly Guthrie and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Medical Care.

In The Last Decade

Gary J. Okano

22 papers receiving 648 citations

Peers

Countries citing papers authored by Gary J. Okano

Since Specialization

Citations

This map shows the geographic impact of Gary J. Okano's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary J. Okano with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary J. Okano more than expected).

Fields of papers citing papers by Gary J. Okano

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gary J. Okano. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary J. Okano. The network helps show where Gary J. Okano may publish in the future.

Co-authorship network of co-authors of Gary J. Okano

This figure shows the co-authorship network connecting the top 25 collaborators of Gary J. Okano. A scholar is included among the top collaborators of Gary J. Okano based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary J. Okano. Gary J. Okano is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Comparative Clinical and Economic Outcomes Associated with Warfarin Versus Apixaban in the Treatment of Patients with Venous Thromboembolism in a Large U.S. Commercial Claims Database 2020 ·Journal of Managed Care & Specialty Pharmacy ·Jennifer D. Guo, (unknown), Patrick Hlavacek, Allison Keshishian, (unknown), (unknown), Mu Qiao, Jack Mardekian, Cristina Russ, Gary J. Okano, Lisa Rosenblatt	4
2	Cost of palliative external beam radiotherapy (EBRT) use for bone metastases secondary to prostate cancer 2015 ·The Journal of Community and Supportive Oncology ·Nancy A. Nickman, Xiangyang Ye, David K. Gaffney, (unknown), Joseph Biskupiak, Gary J. Okano, (unknown), (unknown)	5
3	A disease-specific measure of health-related quality of life in adults with chronic Immune Thrombocytopenic Purpura: Psychometric testing in an open-label clinical trial 2007 ·Clinical Therapeutics ·Susan D. Mathias, James B. Bussel, James N. George, Robert McMillan, Gary J. Okano, Janet L. Nichol	32
4	A disease-specific measure of health-related quality of life for use in adults with immune thrombocytopenic purpura: Its development and validation 2007 ·Health and Quality of Life Outcomes ·Susan D. Mathias, James B. Bussel, James N. George, Robert McMillan, Gary J. Okano, Janet L. Nichol	51
5	The Clinical and Direct Medical Cost Burden of Splenectomy among Managed Care Patients with Chronic Immune Thrombocytopenic Purpura (ITP). 2006 ·Blood ·Louis M. Aledort, Roger M. Lyons, Gary J. Okano, Joseph A. Leveque	4
6	Retrospective Matched Cohort Study of Immune Thrombocytopenic Purpura (ITP): Complications Related to Corticosteroid (CS) Use. 2006 ·Blood ·Louis M. Aledort, Roger M. Lyons, Gary J. Okano, Joseph A. Leveque	12
7	Analysis of Health-Related Quality of Life in Patients Receiving AMG 531 Using the Disease-Specific Immune Thrombocytopenic Purpura Patient Assessment Questionnaire. 2006 ·Blood ·James N. George, James B. Bussel, Robert McMillan, Matthew Guo, Gary J. Okano, Janet L. Nichol	1
8	Screening, Prevention and Socioeconomic Costs Associated with the Treatment of Colorectal Cancer 2003 ·PharmacoEconomics ·Alberto Redaelli, Carole W. Cranor, Gary J. Okano, Pat Ray Reese	37
9	Can Clinical Pharmacists Affect SF-36 Scores in Veterans at High Risk for Medication-Related Problems? 2001 ·Medical Care ·Daniel C. Malone, Barry L. Carter, Sarah J. Billups, Robert J. Valuck, Debra J. Barnette, Charles D. Sintek, Gary J. Okano, Samuel L. Ellis, Douglas F. Covey, Barbara J. Mason, Sandra G. Jue, Jannet M. Carmichael, Kelly Guthrie, (unknown), Robert Dombrowski, Douglas R. Geraets, Mary G. Amato	52
10	Reduced Quality of Life in Veterans at Risk for Drug‐Related Problems 2001 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Gary J. Okano, Daniel C. Malone, Sarah J. Billups, Barry L. Carter, Charles D. Sintek, Douglas F. Covey, Barbara J. Mason, Sandra G. Jue, Jannet M. Carmichael, Kelly Guthrie, Robert Dombrowski, Douglas R. Geraets, Mary G. Amato	11
11	Health-related quality of life of patients with overactive bladder receiving immediate-release tolterodine 2001 ·The European Journal of Health Economics ·Andreas M. Pleil, Pat Ray Reese, Con Kelleher, Gary J. Okano	14
12	An Economic Analysis of a Randomized, Controlled, Multicenter Study of Clinical Pharmacist Interventions for High‐Risk Veterans: The IMPROVE Study 2000 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Daniel C. Malone, Barry L. Carter, Sarah J. Billups, Robert J. Valuck, Debra J. Barnette, Charles D. Sintek, Gary J. Okano, Samuel L. Ellis, Douglas F. Covey, Barbara J. Mason, Sandra G. Jue, Jannet M. Carmichael, Kelly Guthrie, (unknown), Robert Dombrowski, Douglas R. Geraets, Mary G. Amato	75
13	Clinical and Economic Impact of Ambulatory Care Clinical Pharmacists in Management of Dyslipidemia in Older Adults: The IMPROVE Study 2000 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Samuel L. Ellis, Barry L. Carter, Daniel C. Malone, Sarah J. Billups, Gary J. Okano, Robert J. Valuck, Debra J. Barnette, Charles D. Sintek, Douglas F. Covey, Barbara J. Mason, Sandra G. Jue, Jannet M. Carmichael, Kelly Guthrie, Robert Dombrowski, Douglas R. Geraets, Mary G. Amato	126
14	Assessing the structure and process for providing pharmaceutical care in Veterans Affairs medical centers 2000 ·American Journal of Health-System Pharmacy ·Sarah J. Billups, Gary J. Okano, Daniel C. Malone, Barry L. Carter, Robert J. Valuck, Debra J. Barnette, Charles D. Sintek	31
15	Treatment of urge incontinence in veterans affairs medical centers 1999 ·Clinical Therapeutics ·Daniel C. Malone, Gary J. Okano	17
16	Patterns of antihypertensive use among patients in the US Department of Defense database initially prescribed an angiotensin-converting enzyme inhibitor or calcium channel blocker 1997 ·Clinical Therapeutics ·Gary J. Okano, Karen L. Rascati, James P. Wilson, (unknown), John D. Grabenstein, Diana Brixner	41
17	Evaluation of Physician Intervention Letters 1996 ·Medical Care ·Karen L. Rascati, Gary J. Okano, (unknown)	26
18	Effects of Medicaid drug utilization review intervention letters 1995 ·Clinical Therapeutics ·Gary J. Okano, Karen L. Rascati	16
19	Phenolic compounds from stem bark of Acanthopanax senticosus and their pharmacological effect in chronic swimming stressed rats. 1990 ·Chemical and Pharmaceutical Bulletin ·Sansei Nishibe, (unknown), Hajime Takeda, Gary J. Okano	135
20	PC48 PHENOLIC COMPOUNDS FROM ACANTHOPANAX SENTICOSUS AND THEIR PHARMACOLOGICAL EFFECTS ON SWIMMING EXERCISE IN RATS 1988 ·Sansei Nishibe, (unknown), (unknown), Tara N. Fujimoto, Hiroshi Takeda, Izumi Morita, Gary J. Okano, (unknown), Toshio Goto	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact